Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets

This study aimed to develop a biopredictive dissolution method for desvenlafaxine ER tablets using design of experiments (DoE) and physiologically based biopharmaceutics modeling (PBBM) to address the challenge of developing generic drug products by reducing the risk of product failure in pivotal bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carapeto, Gustavo Vaiano, Duque, Marcelo Dutra, Issa, Michele Georges, Ferraz, Humberto Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222762/
https://www.ncbi.nlm.nih.gov/pubmed/37242786
http://dx.doi.org/10.3390/pharmaceutics15051544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222762/
https://www.ncbi.nlm.nih.gov/pubmed/37242786
http://dx.doi.org/10.3390/pharmaceutics15051544

Ejemplares similares